As of 2026-03-31, 广药白云山（广药集团）'s data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 0.00%, below the industry average by 6.9 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 广药白云山（广药集团）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
广药白云山（广药集团）'s Mention Rate is 0.00%, lower than 0.6% of competitors
广药白云山（广药集团）'s First Mention is 0.00%, lower than 0.9% of competitors
广药白云山（广药集团）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
广药白云山（广药集团）'s Positive Rate is 0.00%, lower than 8.9% of competitors
广药白云山（广药集团）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 以以岭药业 | 14.58% | 0% | 0% | 10.42% | 0% | View Details |
| 华华北制药 | 4.17% | 0% | 0% | 0% | 4.17% | View Details |
| 扬扬子江药业集团 | 2.08% | 2.08% | 0% | 2.08% | 0% | View Details |
| 礼礼来 eli lilly | 0% | 0% | 0% | 0% | 0% | View Details |
| 阿阿斯利康 astrazeneca | 0% | 0% | 0% | 0% | 0% | View Details |
| 百百济神州 beigene | 0% | 0% | 0% | 0% | 0% | View Details |
| 广广药白云山（广药集团） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
